Anzeige
Mehr »
Montag, 19.01.2026 - Börsentäglich über 12.000 News
Goldaktie des Tages: Weiteres Upside-Potential enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41WY9 | ISIN: US81256L3024 | Ticker-Symbol:
NASDAQ
16.01.26 | 21:59
2,550 US-Dollar
-0,78 % -0,020
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SEASTAR MEDICAL HOLDING CORPORATION Chart 1 Jahr
5-Tage-Chart
SEASTAR MEDICAL HOLDING CORPORATION 5-Tage-Chart

Aktuelle News zur SEASTAR MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.01.SeaStar Medical Announces 2026 Milestones239Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer base Advance SeaStar Medical's first-in-class SCD therapy for the adult AKI indication - a potential...
► Artikel lesen
23.12.25SeaStar Medical announces 1-for-10 reverse stock split effective Jan 53
23.12.25SeaStar Medical Announces 1-for-10 Reverse Split126DENVER, Dec. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...
► Artikel lesen
SEASTAR MEDICAL Aktie jetzt für 0€ handeln
18.12.25SeaStar Medical: Aktionäre genehmigen Reverse-Split im Verhältnis 1:10 und Aktienreduktion3
18.12.25SeaStar Medical Holding Corp - 8-K, Current Report-
02.12.25SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI144FDA lowers surveillance requirement to 50 patients from 300 patients in original HDE approval based on assessment of first 21 SAVE Surveillance Registry patients Compelling efficacy data to date...
► Artikel lesen
17.11.25Michael Messinger wird neuer CFO bei SeaStar Medical2
17.11.25SeaStar Medical appoints Michael Messinger as new CFO1
17.11.25SeaStar Medical Announces Appointment of Michael Messinger as CFO258DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...
► Artikel lesen
13.11.25SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates159Business highlights include: Three new top-rated children's hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI)Commercial use of QUELIMMUNE therapy demonstrates positive...
► Artikel lesen
13.11.25SeaStar Medical Holding Corp - 10-Q, Quarterly Report-
13.11.25SeaStar Medical Holding Corp - 8-K, Current Report-
12.11.25A Glimpse of SeaStar Medical Holding's Earnings Potential3
05.11.25SeaStar Medical to Report Third Quarter Financial Results on November 13, 20253
29.09.25SeaStar Medical hebt Gehaltskürzungen für Führungsebene auf2
29.09.25SeaStar Medical reports positive data from pediatric AKI therapy registry4
25.09.25ICU Medical-Aktie gibt nach Ausweitung klinischer Studie von SeaStar Medical deutlich nach4
24.09.25SeaStar Medical Holding Corp - 8-K, Current Report3
24.09.25DSMB recommends continuation of SeaStar Medical's AKI trial2
24.09.25SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury2
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1